These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 1990136
1. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis. Longman LP, Pearce PK, McGowan P, Hardy P, Martin MV. J Med Microbiol; 1991 Jan; 34(1):33-7. PubMed ID: 1990136 [Abstract] [Full Text] [Related]
2. Amoxycillin-resistant oral streptococci and experimental infective endocarditis in the rabbit. Longman LP, Marsh PD, Martin MV. J Antimicrob Chemother; 1992 Sep; 30(3):349-52. PubMed ID: 1452500 [Abstract] [Full Text] [Related]
3. Amoxycillin-resistant streptococci in dental plaque. Koh J, Wilson M, Vidic J, Newman HN. Microbios; 1986 Sep; 45(182):41-53. PubMed ID: 3635661 [Abstract] [Full Text] [Related]
4. Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on Streptococcus gordonii and Streptococcus sanguis. Lee SY. J Chemother; 2000 Oct; 12(5):379-84. PubMed ID: 11128556 [Abstract] [Full Text] [Related]
5. [Endocarditis prophylaxis with amoxicillin, clindamycin or erythromycin? Serum bacteriostatic and bactericidal effect against Streptococcus viridans]. Garlando F, Täuber MG, Lüthy R. Dtsch Med Wochenschr; 1988 Jul 08; 113(27):1087-91. PubMed ID: 3292185 [Abstract] [Full Text] [Related]
7. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis. Hsu RB, Lin FY. Cardiology; 2006 Aug 08; 105(4):234-9. PubMed ID: 16534200 [Abstract] [Full Text] [Related]
8. Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment. Mihaila-Amrouche L, Schlegel L, Bouvet A, Association pour l'Etude et la Prévention de l'Endocadite Infectieuse (AEPEI) Study Group. Indian J Med Res; 2004 May 08; 119 Suppl():80-3. PubMed ID: 15232168 [Abstract] [Full Text] [Related]
9. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. Entenza JM, Caldelari I, Glauser MP, Moreillon P. J Antimicrob Chemother; 1999 Dec 08; 44(6):775-86. PubMed ID: 10590278 [Abstract] [Full Text] [Related]
10. Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin. Maskell JP, Sefton AM, Cannell H, Kerawala C, Seymour A, Sun ZM, Williams JD. J Antimicrob Chemother; 1990 Oct 08; 26(4):539-48. PubMed ID: 2254223 [Abstract] [Full Text] [Related]
11. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Tomás I, Alvarez M, Limeres J, Otero JL, Saavedra E, López-Meléndez C, Diz P. Oral Microbiol Immunol; 2004 Oct 08; 19(5):331-5. PubMed ID: 15327647 [Abstract] [Full Text] [Related]
12. Antibiotic susceptibility of streptococcal strains associated with infective endocarditis. Etienne J, Gruer LD, Fleurette J. Eur Heart J; 1984 Oct 08; 5 Suppl C():33-7. PubMed ID: 6394332 [Abstract] [Full Text] [Related]
13. Effect of repeated high dose prophylaxis with amoxycillin on the resident oral flora of adult volunteers. Woodman AJ, Vidic J, Newman HN, Marsh PD. J Med Microbiol; 1985 Feb 08; 19(1):15-23. PubMed ID: 3844036 [Abstract] [Full Text] [Related]
14. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR. Clin Infect Dis; 2001 Aug 15; 33(4):577-9. PubMed ID: 11462199 [Abstract] [Full Text] [Related]
15. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin]. Martínez F, Martín Luengo F, Valdés M. Enferm Infecc Microbiol Clin; 1993 May 15; 11(5):255-9. PubMed ID: 8324022 [Abstract] [Full Text] [Related]
16. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin. Martínez F, Martín-Luengo F, García A, Valdés M. Methods Find Exp Clin Pharmacol; 1994 May 15; 16(4):247-51. PubMed ID: 8051983 [Abstract] [Full Text] [Related]
17. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections. Girard AE, Cimochowski CR, Faiella JA. J Antimicrob Chemother; 1993 Jun 15; 31 Suppl E():29-37. PubMed ID: 8396094 [Abstract] [Full Text] [Related]
18. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin. García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM, Hospital Clinic Experimental Endocarditis Study Group. Antimicrob Agents Chemother; 2013 May 15; 57(5):2319-25. PubMed ID: 23478959 [Abstract] [Full Text] [Related]
19. In-vitro susceptibility of oral streptococci to pristinamycin. Maskell JP, Williams JD. J Antimicrob Chemother; 1987 May 15; 19(5):585-90. PubMed ID: 3112093 [Abstract] [Full Text] [Related]